4 Largecap Low Debt Five-Year Winner Profit CAGR Stocks to Watch for Future Multibagger Potential: Sun Pharma, Eicher Motors, BSE and Polycab
- November 10, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Sun Pharma Rs 1,915. Eicher Motors Rs 7,651. BSE Rs 3,800. Polycab Rs 7,839. Market caps from Rs 1.26 lakh crore to Rs 4.60 lakh crore. Data as of 9 Nov 2026.
Quick Answer
Sun Pharma, Eicher Motors, BSE and Polycab are the 4 picks in this low debt five-year winner profit CAGR stocks watchlist, with market caps between Rs 1.26 lakh crore and Rs 4.60 lakh crore. Sun Pharma stands out for the largest market cap at Rs 4,60,152 crore, while Eicher Motors offers the lowest PE of the group at 36.31. PE ratios run from 36.31 to 57.67, so compare each one with its industry PE before investing. All figures are as of 9 November 2026.
Low debt five-year winner profit CAGR stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, Eicher Motors, BSE and Polycab meet that test, with market caps from Rs 1.26 lakh crore to Rs 4.60 lakh crore and Sun Pharma offering the largest market cap at Rs 4,60,152 crore. Each of these companies has a debt to equity ratio below 0.3, a four year profit CAGR of at least 15 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a debt to equity ratio below 0.3, a four year profit CAGR of at least 15 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening low debt five-year winner profit CAGR stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 9 November 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Low Debt Five-Year Winner Profit CAGR Stocks and Why Do They Attract Multibagger Interest?
Low debt five-year winner profit CAGR stocks are shares of large companies whose borrowing is small compared with shareholder funds, whose profit has compounded at fifteen per cent or more a year over four years and whose share price has at least doubled over five years. The four here cover pharmaceuticals, motorcycles, exchange services and cables.
Low debt shows that growth did not depend on borrowed money, a high profit CAGR shows that earnings have compounded year after year, and a doubled share price shows that the market has rewarded the record. Within low debt five-year winner profit CAGR stocks, the four companies show rising profit. For low debt five-year winner profit CAGR stocks, both FY26 and the latest quarter showed growth. Whichever way you read low debt five-year winner profit CAGR stocks, the common thread is rising profit backed by complete financial data. For low debt five-year winner profit CAGR stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of low debt five-year winner profit CAGR stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for low debt five-year winner profit CAGR stocks before you decide.
Low Debt Five-Year Winner Profit CAGR Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 9 November 2026. Eicher Motors has the lowest PE of the group at 36.31, while BSE posts the highest return on equity at 37.42%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,915 | 4,60,152 | 37.97 | 36.42 | 13.74% | 0.06 | 1,583.70 to 2,046.90 |
| Eicher Motors | 7,651 | 2,09,610 | 36.31 | 23.82 | 21.97% | 0.02 | 6,442.00 to 8,230.00 |
| BSE Ltd | 3,800 | 1,62,734 | 57.67 | 42.42 | 37.42% | 0.00 | 2,326.10 to 4,446.80 |
| Polycab India | 7,839 | 1,26,493 | 43.54 | 49.96 | 22.25% | 0.02 | 6,663.00 to 10,126.00 |
Sun Pharma: 35.75% Profit CAGR Since FY22
Sun Pharmaceutical Industries is one of India’s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 111.23% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 37.97 against an industry PE of 36.42, with a return on equity of 13.74%.
Eicher Motors: 34.67% Profit CAGR Since FY22
Eicher Motors owns the Royal Enfield brand of premium motorcycles and is a partner in the Eicher commercial vehicle business. It reported FY26 revenue of Rs 24,894.09 crore, up 23.39% year on year, and net profit of Rs 5,515.23 crore, up 16.49%. Net profit has compounded at 34.67% a year since FY22, while revenue has grown 23.39% a year. Operating margin was 34.24% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.
The stock trades at a PE of 36.31 against an industry PE of 23.82, with a return on equity of 21.97%. In the June 2026 quarter, revenue rose 29.35% to Rs 7,098.73 crore and net profit grew 21.35% to Rs 1,462.51 crore. The share price has gained 174.02% over five years.
BSE: 78.30% Profit CAGR Since FY22
BSE Ltd operates one of India’s two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026. The stock trades at a PE of 57.67 against an industry PE of 42.42, with a return on equity of 37.42%.
Polycab: 33.79% Profit CAGR Since FY22
Polycab India is a leading maker of wires and cables in India, with a growing fast-moving electrical goods business. It reported FY26 revenue of Rs 29,120.04 crore, up 28.76% year on year, and net profit of Rs 2,708.43 crore, up 32.41%. Net profit has compounded at 33.79% a year since FY22, while revenue has grown 24.06% a year. Operating margin was 14.69% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.
The stock trades at a PE of 43.54 against an industry PE of 49.96, below the sector average, with a return on equity of 22.25%. In the June 2026 quarter, revenue rose 38.90% to Rs 8,314.65 crore and net profit grew 32.84% to Rs 796.65 crore. The share price has gained 234.47% over five years. Foreign investors raised their holding from 11.44% in June 2025 to 19.00% in June 2026.
Low Debt Five-Year Winner Profit CAGR Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these low debt five-year winner profit CAGR stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Sun Pharma | 61,673.94 | 11,564.52 | 12.69% | 11.62% | 35.75% | 32.52% |
| Eicher Motors | 24,894.09 | 5,515.23 | 23.39% | 23.39% | 34.67% | 34.28% |
| BSE | 5,148.10 | 2,475.30 | 59.07% | 56.26% | 78.30% | 77.03% |
| Polycab | 29,120.04 | 2,708.43 | 28.76% | 24.06% | 33.79% | 15.12% |
Check the Univest Screener for live data on these low debt five-year winner profit CAGR stocks
Institutional Holding in Sun Pharma, Eicher Motors, BSE and Polycab
Institutional holding shows who is backing these low debt five-year winner profit CAGR stocks alongside the promoter. The table uses the latest reported quarter for each. BSE has the deepest institutional backing, with FII and DII together holding 45.47% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%) and BSE (from 13.51% to 24.15%). To see how this group fits the wider market, many investors compare it with the Nifty 50.
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Sun Pharma | 52.68% | 14.36% | 22.27% | 10.70% | September 2026 |
| Eicher Motors | 49.02% | 25.53% | 16.06% | 9.40% | June 2026 |
| BSE | Nil | 21.32% | 24.15% | 54.53% | June 2026 |
| Polycab | 61.46% | 19.00% | 7.62% | 11.92% | June 2026 |
Risks to Weigh in Low Debt Five-Year Winner Profit CAGR Stocks
Being careful with low debt five-year winner profit CAGR stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Eicher Motors trades at a PE of 36.31 against an industry PE of 23.82, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Low Debt Five-Year Winner Profit CAGR Stocks
Picking from low debt five-year winner profit CAGR stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (23.82 to 49.96) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Sun Pharma, Eicher Motors, BSE and Polycab live prices.
Conclusion
Among low debt five-year winner profit CAGR stocks, Sun Pharma stands out for the largest market cap at Rs 4,60,152 crore, Eicher Motors for the lowest PE of the group at 36.31, BSE for the highest return on equity at 37.42% and Polycab for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.02. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing low debt five-year winner profit CAGR stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Low Debt Five-Year Winner Profit CAGR Stocks to Watch
Which are the best low debt five-year winner profit CAGR stocks to watch for multibagger potential?
Ans. Sun Pharma, Eicher Motors, BSE and Polycab are the 4 names this list highlights, with market caps of Rs 4,60,152 crore, Rs 2,09,610 crore, Rs 1,62,734 crore and Rs 1,26,493 crore respectively. Sun Pharma is notable for the largest market cap at Rs 4,60,152 crore. Eicher Motors stands out for the lowest PE of the group at 36.31. BSE offers the highest return on equity at 37.42%. Polycab brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.02. These are watchlist names for low debt five-year winner profit CAGR stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is BSE a good stock for long-term investors?
Ans. BSE has a return on equity of 37.42%, a PE of 57.67 against an industry PE of 42.42 and a market cap of Rs 1,62,734 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in low debt five-year winner profit CAGR stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Sun Pharma become a multibagger from here?
Ans. Sun Pharma has already gained 111.23% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in low debt five-year winner profit CAGR stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 37.97 against an industry PE of 36.42, valuation should be checked against that growth before investing.
What is the market cap of Sun Pharma, Eicher Motors, BSE and Polycab?
Ans. As of 9 November 2026, Sun Pharma has a market cap of Rs 4,60,152 crore, Eicher Motors has a market cap of Rs 2,09,610 crore, BSE has a market cap of Rs 1,62,734 crore and Polycab has a market cap of Rs 1,26,493 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on low debt five-year winner profit CAGR stocks.
What are the risks of investing in low debt five-year winner profit CAGR stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Eicher Motors trades at a PE of 36.31 against an industry PE of 23.82, so earnings growth needs to hold up.
Why is Eicher Motors trading at a PE of 36.31?
Ans. Eicher Motors’ PE of 36.31 compares with an industry PE of 23.82. The market is paying a premium for a return on equity of 21.97%, profit growth of 34.67% a year since FY22 and latest-quarter profit growth of 21.35%, which also means the stock is more sensitive if growth slows. Investors in low debt five-year winner profit CAGR stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Sun Pharma, Eicher Motors, BSE and Polycab?
Ans. As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 41.59% of Eicher Motors (25.53% and 16.06%), 45.47% of BSE (21.32% and 24.15%) and 26.62% of Polycab (19.00% and 7.62%). Rising institutional holding is a useful signal in low debt five-year winner profit CAGR stocks, though it should be read with earnings trends rather than on its own.
